<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="generator" content=
"HTML Tidy for HTML5 for Mac OS X version 5.4.0" />
<!-- Document created using Wdesk 1 -->
<!-- Copyright 2018 Workiva -->
<title>Document</title>
</head>
<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s2FBE574041B92FF566563BBB99EFE60A" id=
"s2FBE574041B92FF566563BBB99EFE60A"></a></div>
<div><br /></div>
<div style=
"line-height:120%;padding-top:5px;text-align:center;-sec-extract:summary;font-size:18pt;">
<font style=
"font-family:inherit;font-size:18pt;font-weight:bold;">UNITED
STATES</font></div>
<div style="line-height:120%;text-align:center;font-size:18pt;">
<font style=
"font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES
AND EXCHANGE COMMISSION</font></div>
<div style="line-height:120%;text-align:center;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;font-weight:bold;">Washington,
D.C. 20549</font></div>
<div style="line-height:120%;text-align:center;font-size:18pt;">
<hr />
<font style=
"font-family:inherit;font-size:18pt;font-weight:bold;">FORM
8-K</font><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:center;font-size:12pt;">
<hr />
<font style=
"font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT
REPORT</font></div>
<div style="line-height:120%;text-align:center;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to
Section 13 or 15(d)</font></div>
<div style="line-height:120%;text-align:center;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;font-weight:bold;">of The
Securities Exchange Act of 1934</font></div>
<div style=
"line-height:120%;padding-top:16px;text-align:center;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;font-weight:bold;">Date of
Report (Date of earliest event reported): May 20,
2018</font><font style=
"font-family:inherit;font-size:12pt;">&nbsp;</font><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;">
<hr /></div>
<div style=
"line-height:120%;padding-top:16px;text-align:center;font-size:24pt;">
<font style=
"font-family:inherit;font-size:24pt;font-weight:bold;">CIDARA
THERAPEUTICS, INC.</font></div>
<div style="line-height:120%;text-align:center;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">(Exact name
of registrant as specified in its charter)</font></div>
<div style="line-height:120%;text-align:center;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;">
<hr /></div>
<div style="line-height:120%;text-align:center;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="5"></td>
</tr>
<tr>
<td style="width:32%;"></td>
<td style="width:2%;"></td>
<td style="width:32%;"></td>
<td style="width:2%;"></td>
<td style="width:32%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div>
</td>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">001-36912</font></div>
</td>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">46-1537286</font></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:8pt;"><font style=
"font-family:inherit;font-size:8pt;font-weight:bold;">(State or
other jurisdiction</font></div>
<div style="text-align:center;font-size:8pt;"><font style=
"font-family:inherit;font-size:8pt;font-weight:bold;">of
incorporation)</font></div>
</td>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:8pt;"><font style=
"font-family:inherit;font-size:8pt;font-weight:bold;">(Commission</font></div>
<div style="text-align:center;font-size:8pt;"><font style=
"font-family:inherit;font-size:8pt;font-weight:bold;">File
Number)</font></div>
</td>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:8pt;"><font style=
"font-family:inherit;font-size:8pt;font-weight:bold;">(I.R.S.
Employer</font></div>
<div style="text-align:center;font-size:8pt;"><font style=
"font-family:inherit;font-size:8pt;font-weight:bold;">Identification
No.)</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:center;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="3"></td>
</tr>
<tr>
<td style="width:33%;"></td>
<td style="width:36%;"></td>
<td style="width:31%;"></td>
</tr>
<tr>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">6310 Nancy
Ridge Drive, Suite 101</font></div>
<div style="text-align:center;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">San Diego,
California 92121</font></div>
</td>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:center;font-size:8pt;"><font style=
"font-family:inherit;font-size:8pt;font-weight:bold;">(Address of
principal executive offices, including zip code)</font></div>
</td>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style=
"line-height:120%;padding-top:16px;text-align:center;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Registrant’s
telephone number, including area code: (858)
752-6170</font><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;">
<hr /></div>
<div style=
"line-height:120%;padding-top:16px;text-align:left;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</font></div>
<div style="line-height:120%;text-align:left;font-size:6pt;">
<font style=
"font-family:inherit;font-size:6pt;">&nbsp;</font></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:4%;"></td>
<td style="width:96%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">☐</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Written communications
pursuant to Rule 425 under the Securities Act (17 CFR
230.425)</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:4%;"></td>
<td style="width:96%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">☐</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:4%;"></td>
<td style="width:96%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">☐</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:4%;"></td>
<td style="width:96%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">☐</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:left;font-size:6pt;">
<font style=
"font-family:inherit;font-size:6pt;">&nbsp;</font></div>
<div style="line-height:144%;text-align:left;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">&nbsp;Indicate by
check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§ 240.12b-2 of this chapter).&nbsp;</font></div>
<div style="line-height:144%;text-align:left;font-size:6pt;">
<font style=
"font-family:inherit;font-size:6pt;"><br /></font></div>
<div style="line-height:144%;text-align:left;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">Emerging growth
company</font> <font style=
"font-family:Wingdings;font-size:10pt;">x</font></div>
<div style="line-height:144%;text-align:left;font-size:6pt;">
<font style=
"font-family:inherit;font-size:6pt;"><br /></font></div>
<div style="line-height:144%;text-align:left;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">If an emerging
growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.</font> <font style=
"font-family:Wingdings;font-size:10pt;">¨</font></div>
<div style="line-height:120%;text-align:left;font-size:6pt;">
<font style=
"font-family:inherit;font-size:6pt;"><br /></font></div>
<div><br /></div>
<hr style="page-break-after:always" />
<div><br /></div>
<div style="line-height:120%;">
<hr /></div>
<div style=
"line-height:120%;padding-top:16px;text-align:left;font-size:11pt;">
<font style=
"font-family:inherit;font-size:11pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:left;font-size:11pt;">
<font style=
"font-family:inherit;font-size:11pt;"><br /></font></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:58.92857142857143%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:18%;"></td>
<td style="width:82%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Item
1.01</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Entry into a
Material Definitive Agreement.</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">On May 21, 2018,
Cidara Therapeutics, Inc. (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Compan</font><font style="font-family:inherit;font-size:10pt;">y”
) entered into a Subscription Agreement (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Subscription
Agreement”</font><font style=
"font-family:inherit;font-size:10pt;">) with certain purchasers
identified on the signature pages thereto (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Purchasers”
</font><font style="font-family:inherit;font-size:10pt;">),
pursuant to which the Company will offer to the Purchasers, in a
registered direct offering, up to an aggregate of $120.0 million of
shares of common stock, par value $0.0001 per share (
“</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Common
Stock”</font><font style="font-family:inherit;font-size:10pt;">),
in three closings. The Company will offer 10,638,297 shares of
Common Stock in the first closing of the offering at a negotiated
purchase price of $4.70 per share, for aggregate gross proceeds to
the Company of approximately $50.0 million, before deducting fees
to the placement agents and other estimated offering expenses
payable by the Company.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">In the second
closing of the offering, the Company may sell up to an additional
$50.0 million of shares of Common Stock to investors who purchased
at least $1.0 million of shares of Common Stock in the first
closing of the offering (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Major
Purchasers”</font><font style=
"font-family:inherit;font-size:10pt;">) at a purchase price per
share that is equal to 75% of the volume weighted average price of
the Common Stock for the five trading days following the Company’s
public release of Part B topline data from its STRIVE global,
randomized Phase 2 clinical trial of rezafungin, provided that the
Company will not be obligated to complete the second closing of the
offering if the purchase price is less than $4.70 per share. The
Major Purchasers will participate in the second closing pro rata,
with each Major Purchaser’s pro rata amount being equal to such
investor’s first closing purchase price divided by the aggregate
purchase price paid by all Major Purchasers. In the event that
there are any amounts not purchased in the second closing by the
Major Purchasers, the other Major Purchasers participating in the
second closing may purchase, on a pro rata basis, such remaining
unsold amount, subject to the requirements of the listing rules of
the Nasdaq Stock Market LLC. At the Company’s option, and prior to
the completion of the second closing, the Company may reduce the
aggregate offering size of the second closing by the dollar amount
received by the Company from any (i) strategic partnership or other
non-dilutive source of funding or (ii) sale of equity securities at
a price greater than $6.81 per share.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">In the optional
third closing, which would be held five trading days following the
second closing, purchasers who fully participate in the second
closing may, at their option, purchase up to an additional $20.0
million of Common Stock at a purchase price per share equal to the
purchase price of the shares purchased at the second closing. Each
such fully participating investor’s participation will be pro rata
in relation to such investor’s purchase price paid in the second
closing, divided by the aggregate purchase price paid by all
investors who participate in the second closing, subject to the
requirements of the listing rules of the Nasdaq Stock Market LLC.
At the Company’s option, and prior to the completion of the third
closing, the Company may reduce the aggregate offering size of the
optional third closing by the dollar amount received by the Company
from any (i) strategic partnership or other non-dilutive source of
funding or (ii) sale of equity securities at a price greater than
$6.81 per share.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The Company will
also offer to each Purchaser in the offering the opportunity, in
lieu of purchasing Common Stock, to purchase Series X convertible
preferred stock (“</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Series
X Preferred Stock”</font><font style=
"font-family:inherit;font-size:10pt;">). For each share of Series X
Preferred Stock purchased in the offering in lieu of Common Stock,
the Company will reduce the number of shares of Common Stock being
sold in the offering by 10 shares. Each share of Series X Preferred
Stock is convertible into 10 shares of Common Stock (subject to
adjustment as provided in the related Certificate of Designation of
Preferences, Rights and Limitations of Series X Convertible
Preferred Stock (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Certificate
of Designation”</font><font style=
"font-family:inherit;font-size:10pt;">)). In the event of the
Company’s liquidation, dissolution or winding up, holders of Series
X Preferred Stock will participate pari passu with any distribution
of proceeds to holders of Common Stock. Holders of Series X
Preferred Stock are entitled to receive dividends on shares of
Series X Preferred Stock equal (on an as if converted to common
stock basis) to and in the same form as dividends actually paid on
the Common Stock or other junior securities. Shares of Series X
Preferred Stock will generally have no voting rights, except as
required by law and except that the consent of the holders of a
majority of the outstanding Series X Preferred Stock will be
required to amend the terms of the Series X Preferred Stock and to
approve certain corporate actions.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The Common Stock
and the Series X Preferred Stock being sold by the Company in this
offering are being offered by the Company pursuant to an effective
shelf registration statement on Form S-3, which was originally
filed with the Securities and Exchange Commission on May 20, 2016,
and was declared effective on June 1, 2016 (File No. 333-211472)
(the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Registration
Statement”</font><font style=
"font-family:inherit;font-size:10pt;">).</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">In a private
placement concurrent with the first closing (the 
“</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">First
Private Placement”</font><font style=
"font-family:inherit;font-size:10pt;">), the Company is also
selling to the</font></div>
<div><br /></div>
<hr style="page-break-after:always" />
<div><br /></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">Major Purchasers
warrants, at a purchase price of $0.125 per share subject to each
such warrant, to purchase an aggregate of 12,500,000 shares of
Common Stock.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">In a private
placement to be held concurrently with the optional third closing
(the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Second
Private Placement”</font><font style=
"font-family:inherit;font-size:10pt;">), the Company would sell
warrants to purchase up to 2,500,000 shares of Common Stock to the
Major Purchasers who purchase Common Stock in such closing, at a
purchase price of $0.125 per share subject to each such warrant
(such warrants, together with the warrants sold in the First
Private Placement, each, a “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Warrant”
</font><font style="font-family:inherit;font-size:10pt;">, and
collectively, the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Warrants”
</font><font style=
"font-family:inherit;font-size:10pt;">).</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The Warrants will
be exercisable immediately for cash, at an exercise price of $6.81
per share. The Warrants issued in the First Private Placement will
expire upon the earliest of (i) five years from the date of the
first closing of the offering, (ii) the date that the holder of
such Warrant transfers or sells any of the shares of Common Stock
purchased by such holder in the first closing of the offering, if
such transfer or sale occurs prior to the date that is 120 calendar
days following the closing of the first closing of the offering,
(iii) the taking of any short position on the Common Stock by the
holder of such Warrant prior to the completion of the second
closing of the offering, and (iv) the failure by the holder of such
Warrant to purchase its pro rata allocation of shares of Common
Stock in the second closing of the offering.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The Warrants
issued in the Second Private Placement will expire five years from
the date of the third closing of the offering.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The exercise
price and number of shares of Common Stock issuable upon the
exercise of the Warrants (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Warrant
Shares”</font><font style="font-family:inherit;font-size:10pt;">)
will be subject to adjustment in the event of any stock dividends
and splits, reverse stock split, recapitalization, reorganization
or similar transaction, as described in the Warrants.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:12pt;">
<font style="font-family:inherit;font-size:10pt;">The Warrants and
the Warrant Shares are not being registered under the Securities
Act of 1933, as amended (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Securities
Act”</font><font style="font-family:inherit;font-size:10pt;">),
pursuant to the Registration Statement and are instead being
offered pursuant to the exemption provided in Section 4(a)(2) under
the Securities Act and Rule 506(b) promulgated thereunder. Each
Purchaser is either (i) an “accredited investor” as defined in Rule
501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities
Act</font> <font style="font-family:inherit;font-size:10pt;">or
(ii) a “qualified institutional buyer” as defined in Rule 144A(a)
under the Securities Act.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">Citigroup Global
Markets, Inc. and Cantor Fitzgerald &amp; Co. (“</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cantor”
</font><font style="font-family:inherit;font-size:10pt;">) acted as
the co-lead placement agents (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Placement
Agents”</font><font style="font-family:inherit;font-size:10pt;">)
for the Company, on a “reasonable best efforts” basis, in
connection with the offering. A copy of the Placement Agency
Agreement, dated as of May 21, 2018, by and between the Company and
the Placement Agents is attached hereto as Exhibit 10.2 and
incorporated herein by reference (the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Placement
Agency Agreement”</font><font style=
"font-family:inherit;font-size:10pt;">). Pursuant to the Placement
Agency Agreement, the Placement Agents will be entitled to a cash
fee of $1,950,000 for the entire offering.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The foregoing
summaries of the offering, the securities to be issued in
connection therewith, the Subscription Agreement, the Placement
Agency Agreement and the Warrants do not purport to be complete and
are qualified in their entirety by reference to the definitive
transaction documents. Copies of the Subscription Agreement, the
Placement Agency Agreement and the forms of Warrant are attached
hereto as Exhibits 10.1, 10.2, 4.1 and 4.2, respectively, and are
incorporated herein by reference.</font></div>
<div style="line-height:120%;text-align:left;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:left;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">On May 21, 2018,
the Company issued a press release announcing the offering
described above, a copy of which is attached hereto as Exhibit
99.1.</font></div>
<div style="line-height:120%;text-align:left;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;"><br /></font></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:10%;"></td>
<td style="width:90%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Item
1.02</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Termination
of a Material Definitive Agreement</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:left;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">On May 20, 2018,
the Company voluntarily terminated the Controlled Equity
Offering</font><font style=
"font-family:inherit;font-size:10pt;"><sup style=
"vertical-align:top;line-height:120%;font-size:7pt">SM</sup></font>
<font style="font-family:inherit;font-size:10pt;">Sales Agreement
(the “</font><font style=
"font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sales
Agreement</font><font style="font-family:inherit;font-size:10pt;">”
) that the Company entered into on May 19, 2016, with Cantor.
Pursuant to the Sales Agreement, upon the terms and subject to the
conditions and limitations set forth therein, Cantor was committed
to use commercially reasonable efforts to sell up to an aggregate
of $35.0 million of shares of Common Stock over the term of the
Sales Agreement.</font></div>
<div style="line-height:120%;text-align:left;font-size:12pt;">
<font style=
"font-family:inherit;font-size:12pt;"><br /></font></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:10%;"></td>
<td style="width:90%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Item
3.02</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Unregistered
Sales of Equity Securities</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">Please see the
disclosure regarding the Warrants and the Warrant Shares set forth
under Item 1.01, which is incorporated by reference into this Item
3.02.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;&nbsp;</font></div>
<div><br /></div>
<hr style="page-break-after:always" />
<div><br /></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:10%;"></td>
<td style="width:90%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Item
3.03</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Material
Modifications to Rights of Security Holders</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">On May 21, 2018,
the Company, in connection with the registered direct offering of
its Series X Preferred Stock described above, designated 5,000,000
shares of its authorized and unissued preferred stock as Series X
Preferred Stock and filed the Certificate of Designation with the
Secretary of State of Delaware, which is attached hereto as Exhibit
3.1. A summary of the rights, preferences and privileges of the
Series X Preferred Stock is included above under “Item 1.01 Entry
into a Material Definitive Agreement,” which is incorporated by
reference herein.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The above
description of the Certificate of Designation does not purport to
be complete and is qualified in its entirety by reference to the
Certificate of Designation filed as Exhibit 3.1 to this Current
Report on Form 8-K, which is incorporated herein by
reference.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:10%;"></td>
<td style="width:90%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Item
5.03</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Amendments
to Articles of Incorporation or Bylaws; Changes in Fiscal
Year</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">On May 21, 2018,
the Company filed the Certificate of Designation, a copy of which
is attached hereto as Exhibit 3.1. The Certificate of Designation,
establishes and designates the Series X Preferred Stock and the
rights, preferences and privileges thereof.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">The description
of the Certificate of Designation contained in Item 1.01 and Item
3.03 is incorporated herein by reference.</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;"><br /></font></div>
<div style=
"line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:11%;"></td>
<td style="width:89%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Item
9.01</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">Financial
Statements and Exhibits.</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:justify;font-size:11pt;">
<font style=
"font-family:inherit;font-size:11pt;">&nbsp;</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">(d)
Exhibits</font></div>
<div style="line-height:120%;text-align:justify;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="2"></td>
</tr>
<tr>
<td style="width:5%;"></td>
<td style="width:95%;"></td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">3.1</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex312018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Certificate of Designation of
Preferences, Rights and Limitations of Series X Convertible
Preferred Stock</font></a></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">4.1</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex412018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Form of Common Stock Purchase
Warrant for First Private Placement</font></a></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">4.2</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex422018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Form of Common Stock Purchase
Warrant for Second Private Placement</font></a></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">5.1</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex512018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Opinion of Cooley
LLP</font></a></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">10.1</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex1012018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Subscription
Agreement</font></a></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">10.2</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex1022018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Placement Agency
Agreement</font></a></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">23.1</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex512018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Consent of Cooley LLP
(included in Exhibit 5.1)</font></a></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">99.1</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:justify;font-size:10pt;"><a style=
"text-decoration:underline;color:#0000FF;-sec-extract:exhibit;"
href="ex9912018-05x21.htm"><font style=
"font-family:inherit;font-size:10pt;">Press
Release</font></a></div>
</td>
</tr>
</table>
</div>
</div>
<div><br /></div>
<hr style="page-break-after:always" />
<div><br /></div>
<div style="line-height:120%;text-align:left;font-size:11pt;">
<font style=
"font-family:inherit;font-size:11pt;"><br /></font></div>
<div style=
"line-height:120%;padding-top:14px;text-align:center;font-size:10pt;">
<font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div>
<div style=
"line-height:120%;padding-top:16px;text-align:left;font-size:10pt;">
<font style="font-family:inherit;font-size:10pt;">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.</font></div>
<div style="line-height:120%;text-align:left;font-size:11pt;">
<font style=
"font-family:inherit;font-size:11pt;">&nbsp;</font></div>
<div style="line-height:120%;padding-left:4px;font-size:10pt;">
<div style=
"padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;">
<table cellpadding="0" cellspacing="0" style=
"font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;">
<tr>
<td colspan="3"></td>
</tr>
<tr>
<td style="width:58%;"></td>
<td style="width:7%;"></td>
<td style="width:35%;"></td>
</tr>
<tr>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td colspan="2" style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;font-weight:bold;">CIDARA
THERAPEUTICS, INC.</font></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Dated: May 21,
2018</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">By:</font></div>
</td>
<td style=
"vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">/s/ Jeffrey Stein,
Ph.D.</font></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Name:</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Jeffrey Stein,
Ph.D.</font></div>
</td>
</tr>
<tr>
<td style=
"vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="overflow:hidden;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">&nbsp;</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">Title:</font></div>
</td>
<td style=
"vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;">
<div style="text-align:left;font-size:10pt;"><font style=
"font-family:inherit;font-size:10pt;">President and Chief Executive
Officer</font></div>
</td>
</tr>
</table>
</div>
</div>
<div style="line-height:120%;text-align:left;font-size:11pt;">
<font style=
"font-family:inherit;font-size:11pt;"><br /></font></div>
<div><br /></div>
</body>
</html>

